“Small is beautiful.”
E. F. Schumacher
Et si l'utilisation de vésicules extracellulaires et de nanobodies anti-CD38 pouvait venir en aide à la lutte contre le myelome multiple ? C'est la question à laquelle Alexis Dogliani, thésard chez NabGen, tente de répondre 🔬
NabGen
A technological platform dedicated to the generation of nanobodies.
Born from a decade of an industrial collaboration with an expert society in the field of therapeutics antibodies, NabGen Technology is a technological platform of the Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM) located in Marseille, France.
NabGen Technology specialised in the generation of nanobodies and developps an innovative technology : extracellular vesicles.
Major actor of more than a hundred sicentific collaborations since its creation, NabGen Technology puts its expertise in the project handling at the service of its clients.